STOCK TITAN

[IRANNOTICE] LivaNova PLC SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
IRANNOTICE

Rhea-AI Filing Summary

LivaNova PLC submitted a notice under Section 219 of the Iran Threat Reduction and Syria Human Rights Act and Section 13(r) that it made the required disclosure in its Annual Report on Form 10-K for the period ended December 31, 2025. The company states the disclosure appears in Part I, Item 1. Business of the Form 10-K.

The notice, dated February 25, 2026, is a formal attestation that the specified Iran/Syria-related disclosure was included in the filed annual report.

Positive

  • None.

Negative

  • None.

Insights

Routine regulatory attestation confirming disclosure location in the 10-K.

The submission confirms that the Iran Threat Reduction and Syria Human Rights Act and Section 13(r) disclosure is included in Part I, Item 1. Business of the Form 10-K for the period ended December 31, 2025.

Because this is an attestation of inclusion rather than new substantive allegations or actions, the filing mainly documents compliance; any further material detail would appear in the 10-K text itself.






livanovaimagea.jpg



U.S. Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549

February 25, 2026

Re: Notice of Disclosure Filed in Exchange Act Quarterly Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934

Ladies and Gentlemen:

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that LivaNova PLC has made disclosure pursuant to those provisions in its Annual Report on Form 10-K for the period ended December 31, 2025, which was filed with the Securities and Exchange Commission on February 25, 2026. The disclosure can be found within Part I, Item 1. Business in the Annual Report on Form 10-K.


Respectfully submitted,

LivaNova PLC


By:/s/ VLADIMIR MAKATSARIA
Vladimir Makatsaria
Chief Executive Officer


By:/s/ ALEX SHVARTSBURG
Alex Shvartsburg
Chief Financial Officer

Livanova Plc

NASDAQ:LIVN

LIVN Rankings

LIVN Latest News

LIVN Latest SEC Filings

LIVN Stock Data

3.84B
54.41M
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United Kingdom
LONDON